JULIE HUSS: Open Payments
NPI 1548591043 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$142 in 8 payments from 6 companies in 2025. Trend: 2023 $383 · 2024 $237 · 2025 $142
Food & beverage: $142
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| ARRAY BIOPHARMA INC | 1 | $22 |
| Genmab U.S., Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $15 |
| Celgene Corporation | 1 | $14 |
Products named: OPDIVO, SCEMBLIX, LORBRENA, Tivdak, KISQALI, KEYTRUDA, REBLOZYL.
Industry payments across NY — which companies pay providers there.
